# Study of the Efficacy of PedyPhar® Ointment on the Diabetic Foot Ulcers

> **NCT01531517** · PHASE3 · TERMINATED · sponsor: **European Egyptian Pharmaceutical Industries** · enrollment: 47 (actual)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **DRUG:** Royal Jelly and Panthenol (PedyPhar® Ointment)
- **DRUG:** Panthenol Ointment

## Key facts

- **NCT ID:** NCT01531517
- **Lead sponsor:** European Egyptian Pharmaceutical Industries
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-07
- **Primary completion:** 2012-07
- **Final completion:** 2013-07
- **Target enrollment:** 47 (ACTUAL)
- **Why stopped:** inability to recruit patients
- **Last updated:** 2015-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01531517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01531517, "Study of the Efficacy of PedyPhar® Ointment on the Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT01531517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*